Psoriasis and Metabolic Syndrome


Autoria(s): Sales, R.; Torres, T.
Data(s)

04/05/2015

04/05/2015

2014

Resumo

Psoriasis is a chronic, systemic inflammatory disease associated with several cardiometabolic comorbidities, such as obesity, insulin resistance, dyslipidemia, and hypertension, and with clinically significant increased risk of cardiovascular disease and cardiovascular mortality. These comorbidities are components of the metabolic syndrome. Multiple epidemiologic studies have revealed a high prevalence of metabolic syndrome in patients with psoriasis compared with other skin diseases. Genetic susceptibility and overlapping inflammatory pathways may be potential biologic links underlying this association. Understanding the interrelationship between these conditions is important for the management of psoriasis and its associated comorbidities. This review will focus on the range of these comorbidities, with emphasis on the metabolic syndrome, aiming to encourage physicians to screen patients with psoriasis for cardiometabolic disorders and risk factors

Identificador

Acta Dermatovenerol Croat 2014;22(3):169-174

1330-027X

http://hdl.handle.net/10400.16/1777

Idioma(s)

eng

Publicador

Croatian Dermatovenerological Society

Relação

http://adc.mef.hr/index.php/adc/issue/view/48

Direitos

openAccess

Palavras-Chave #metabolic syndrome #psoriasis #cardiovascular disease #atherosclerosis #insulin resistance
Tipo

article